AAAAAA

   
Results: 1-25 | 26-50 | 51-68
Results: 26-50/68
PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION - WHERE DO WE STAND - CHAIRMANS SUMMARY OF THE EUROPEAN-SCHOOL-OF-ONCOLOGY TASK-FORCE MEETING PERIPHERAL-BLOOD PROGENITOR CELLS HELD SEPTEMBER 29-30, 1995 - INTRODUCTION
Authors: BOOGAERTS MA BRUGGER W CARELLA AM CORTESFUNES H FIBBE WE HOWS J KHAYAT D LINCH DC LINK H MOORE MAS TESTA NG
Citation: Ma. Boogaerts et al., PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION - WHERE DO WE STAND - CHAIRMANS SUMMARY OF THE EUROPEAN-SCHOOL-OF-ONCOLOGY TASK-FORCE MEETING PERIPHERAL-BLOOD PROGENITOR CELLS HELD SEPTEMBER 29-30, 1995 - INTRODUCTION, Annals of oncology, 7, 1996, pp. 1-4
TREATMENT OF PATIENTS WITH MYELODYSPLASTIC SYNDROMES WITH ALLOGENEIC BONE-MARROW TRANSPLANTATION FROM GENOTYPICALLY HLA-IDENTICAL SIBLINGS AND ALTERNATIVE DONORS
Authors: DEMUYNCK H VERHOEF GEG ZACHEE P EMONDS MP VANDERSCHUEREN E VANDENBERGHE H VANDENBERGHE P CASTEELSVANDAELE M BOOGAERTS MA
Citation: H. Demuynck et al., TREATMENT OF PATIENTS WITH MYELODYSPLASTIC SYNDROMES WITH ALLOGENEIC BONE-MARROW TRANSPLANTATION FROM GENOTYPICALLY HLA-IDENTICAL SIBLINGS AND ALTERNATIVE DONORS, Bone marrow transplantation, 17(5), 1996, pp. 745-751
RANDOMIZED TRIAL OF FILGRASTIM-MOBILIZED PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION VERSUS AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN LYMPHOMA PATIENTS
Authors: SCHMITZ N LINCH DC DREGER P GOLDSTONE AH BOOGAERTS MA FERRANT A DEMUYNCK HMS LINK H ZANDER A BARGE A BORKETT K
Citation: N. Schmitz et al., RANDOMIZED TRIAL OF FILGRASTIM-MOBILIZED PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION VERSUS AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN LYMPHOMA PATIENTS, Lancet, 347(8998), 1996, pp. 353-357
FEASIBILITY OF PERIPHERAL-BLOOD PROGENITOR-CELL HARVEST AND TRANSPLANTATION IN PATIENTS WITH POOR-RISK MYELODYSPLASTIC SYNDROMES
Authors: DEMUYNCK H DELFORGE M VERHOEF GEG ZACHEE P VANDENBERGHE P VANDENBERGHE H BOOGAERTS MA
Citation: H. Demuynck et al., FEASIBILITY OF PERIPHERAL-BLOOD PROGENITOR-CELL HARVEST AND TRANSPLANTATION IN PATIENTS WITH POOR-RISK MYELODYSPLASTIC SYNDROMES, British Journal of Haematology, 92(2), 1996, pp. 351-359
EVALUATION OF AUTOLOGOUS BONE-MARROW (ABMT) AND AUTOLOGOUS PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION (PBPCT) IN ACUTE MYELOID-LEUKEMIA (AML)
Authors: DEMUYNCK H VERHOEF GEG MAERTENS J VANDENBERGHE P ZACHEE P BOOGAERTS MA
Citation: H. Demuynck et al., EVALUATION OF AUTOLOGOUS BONE-MARROW (ABMT) AND AUTOLOGOUS PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION (PBPCT) IN ACUTE MYELOID-LEUKEMIA (AML), Blood, 88(10), 1996, pp. 3741-3741
INTENSIVE CHEMOTHERAPY FOLLOWED BY AUTOLOGOUS PROGENITOR-CELL TRANSPLANTATION MAY LEAD TO PROLONGED HEMATOLOGICAL AND MOLECULAR REMISSION IN CHRONIC LYMPHOCYTIC-LEUKEMIA (CLL)
Authors: DEMUYNCK H VERHOEF GEG MAERTENS J VANDENBERGHE P ZACHEE P TIERENS A DELABIE J BOOGAERTS MA
Citation: H. Demuynck et al., INTENSIVE CHEMOTHERAPY FOLLOWED BY AUTOLOGOUS PROGENITOR-CELL TRANSPLANTATION MAY LEAD TO PROLONGED HEMATOLOGICAL AND MOLECULAR REMISSION IN CHRONIC LYMPHOCYTIC-LEUKEMIA (CLL), Blood, 88(10), 1996, pp. 488-488
CD34(-DR-PROGENITOR CELLS IN CHRONIC PHASE CML BUT NOT IN MORE ADVANCED PHASE CML ARE POLYCLONAL()HLA)
Authors: DELFORGE M BOOGAERTS MA MCGLAVE PB VERFAILLIE CM
Citation: M. Delforge et al., CD34(-DR-PROGENITOR CELLS IN CHRONIC PHASE CML BUT NOT IN MORE ADVANCED PHASE CML ARE POLYCLONAL()HLA), Blood, 88(10), 1996, pp. 907-907
TREATMENT OF PRIMARY AMYLOIDOSIS WITH VAD COMBINATION CHEMOTHERAPY RESULTS IN IMPROVED SURVIVAL
Authors: VANEYGEN K ZACHEE P MAERTENS J VANDENBERGHE P DEMUYNCK H VERHOEF G BOOGAERTS MA
Citation: K. Vaneygen et al., TREATMENT OF PRIMARY AMYLOIDOSIS WITH VAD COMBINATION CHEMOTHERAPY RESULTS IN IMPROVED SURVIVAL, Blood, 88(10), 1996, pp. 2351-2351
RECOMBINANT-HUMAN-ERYTHROPOIETIN IN TRANSFUSION-DEPENDENT ANEMIC PATIENTS WITH MULTIPLE-MYELOMA AND NON-HODGKINS-LYMPHOMA - A RANDOMIZED MULTICENTER STUDY
Authors: OSTERBORG A BOOGAERTS MA CIMINO R ESSERS U HOLOWIECKI J JULIUSSON G JAGER G NAJMAN A PEEST D
Citation: A. Osterborg et al., RECOMBINANT-HUMAN-ERYTHROPOIETIN IN TRANSFUSION-DEPENDENT ANEMIC PATIENTS WITH MULTIPLE-MYELOMA AND NON-HODGKINS-LYMPHOMA - A RANDOMIZED MULTICENTER STUDY, Blood, 87(7), 1996, pp. 2675-2682
CYTOGENETICS AND ITS PROGNOSTIC VALUE IN MYELODYSPLASTIC SYNDROMES
Authors: VERHOEF GEG BOOGAERTS MA
Citation: Geg. Verhoef et Ma. Boogaerts, CYTOGENETICS AND ITS PROGNOSTIC VALUE IN MYELODYSPLASTIC SYNDROMES, Acta haematologica, 95(2), 1996, pp. 95-101
GRAFT-VERSUS-LEUKEMIA AND GRAFT-VERSUS-LYMPHOMA EFFECTS OF ALLOGENEICBONE-MARROW TRANSPLANTATION AND OF ALLOGENEIC DONOR LEUKOCYTE TRANSFUSIONS
Authors: VANDENBERGHE P BOOGAERTS MA
Citation: P. Vandenberghe et Ma. Boogaerts, GRAFT-VERSUS-LEUKEMIA AND GRAFT-VERSUS-LYMPHOMA EFFECTS OF ALLOGENEICBONE-MARROW TRANSPLANTATION AND OF ALLOGENEIC DONOR LEUKOCYTE TRANSFUSIONS, Annals of hematology, 71(5), 1995, pp. 209-217
FAB CLASSIFICATION OF MYELODYSPLASTIC SYNDROMES - MERITS AND CONTROVERSIES
Authors: VERHOEF GEG PITTALUGA S DEWOLFPEETERS C BOOGAERTS MA
Citation: Geg. Verhoef et al., FAB CLASSIFICATION OF MYELODYSPLASTIC SYNDROMES - MERITS AND CONTROVERSIES, Annals of hematology, 71(1), 1995, pp. 3-11
AN UPDATE ON PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION
Authors: DEMUYNCK H DELFORGE M ZACHEE P VERHOEF GEG VANDENBERGHE P BOOGAERTS MA
Citation: H. Demuynck et al., AN UPDATE ON PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION, Annals of hematology, 71(1), 1995, pp. 29-33
RISKS OF RHG-CSF TREATMENT IN DRUG-INDUCED AGRANULOCYTOSIS
Authors: DEMUYNCK H ZACHEE P VERHOEF GEG SCHETZ M VANDENBERGHE G LAUWERS P BOOGAERTS MA
Citation: H. Demuynck et al., RISKS OF RHG-CSF TREATMENT IN DRUG-INDUCED AGRANULOCYTOSIS, Annals of hematology, 70(3), 1995, pp. 143-147
DETECTION OF P-GLYCOPROTEIN WITH A RAPID FLOW CYTOMETRIC FUNCTIONAL ASSAY USING FLUO-3 - EVALUATION OF SENSITIVITY, SPECIFICITY AND FEASIBILITY IN MULTIPARAMETRIC ANALYSIS
Authors: VANACKER KL DEGREEF C EGGERMONT J ZHANG P VANDENBERGHE P BOOGAERTS MA
Citation: Kl. Vanacker et al., DETECTION OF P-GLYCOPROTEIN WITH A RAPID FLOW CYTOMETRIC FUNCTIONAL ASSAY USING FLUO-3 - EVALUATION OF SENSITIVITY, SPECIFICITY AND FEASIBILITY IN MULTIPARAMETRIC ANALYSIS, Leukemia, 9(8), 1995, pp. 1398-1406
ANTIINFECTIVE STRATEGIES IN NEUTROPENIA
Authors: BOOGAERTS MA
Citation: Ma. Boogaerts, ANTIINFECTIVE STRATEGIES IN NEUTROPENIA, Journal of antimicrobial chemotherapy, 36, 1995, pp. 167-178
EQUIVALENT EFFICACIES OF MEROPENEM AND CEFTAZIDIME AS EMPIRICAL MONOTHERAPY OF FEBRILE NEUTROPENIC PATIENTS
Authors: BOOGAERTS MA DEMUYNCK H MESTDAGH N VERBIST L GOLDSTONE AH KELSEY HC MACHIN S DEPAUW BE DONNELLY JP RAEMAEKERS JMM ATKINSON G WILLIAMS KJ
Citation: Ma. Boogaerts et al., EQUIVALENT EFFICACIES OF MEROPENEM AND CEFTAZIDIME AS EMPIRICAL MONOTHERAPY OF FEBRILE NEUTROPENIC PATIENTS, Journal of antimicrobial chemotherapy, 36(1), 1995, pp. 185-200
THERAPY-RELATED ACUTE MYELOID-LEUKEMIA WITH T(8-16)(P11-P13) FOLLOWING ANTHRACYCLINE-BASED THERAPY FOR NONMETASTATIC OSTEOSARCOMA
Authors: DEMUYNCK H VERHOEF GEG ZACHEE P VANDENBERGHE P VANORSHOVEN A PARIDAENS R SAMSON I BOOGAERTS MA
Citation: H. Demuynck et al., THERAPY-RELATED ACUTE MYELOID-LEUKEMIA WITH T(8-16)(P11-P13) FOLLOWING ANTHRACYCLINE-BASED THERAPY FOR NONMETASTATIC OSTEOSARCOMA, Cancer genetics and cytogenetics, 82(2), 1995, pp. 103-105
REDUCED GLUTATHIONE FOR THE TREATMENT OF ANEMIA DURING HEMODIALYSIS -A PRELIMINARY COMMUNICATION
Authors: ZACHEE P FERRANT A DAELEMANS R GOOSSENS W BOOGAERTS MA LINS RL
Citation: P. Zachee et al., REDUCED GLUTATHIONE FOR THE TREATMENT OF ANEMIA DURING HEMODIALYSIS -A PRELIMINARY COMMUNICATION, Nephron, 71(3), 1995, pp. 343-349
REPOPULATION AFTER AUTOLOGOUS BONE-MARROW VERSUS PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION IN YOUNGER PATIENTS WITH HIGH-RISK MYELODYSPLASTIC SYNDROMES IN COMPLETE REMISSION AFTER INTENSIFIED INDUCTION THERAPY - A JOINT EORTC EBMT STUDY/
Authors: BOOGAERTS MA DEMUYNCK H DEWITTE T SUCIU S LABAR B ARCHIMBAUD E RUNDE V SELLESLAG D ZITTOUN R LELIE JVD MUUS P DARDENNE M WILLEMZE R GRATWOHL A APPERLEY J
Citation: Ma. Boogaerts et al., REPOPULATION AFTER AUTOLOGOUS BONE-MARROW VERSUS PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION IN YOUNGER PATIENTS WITH HIGH-RISK MYELODYSPLASTIC SYNDROMES IN COMPLETE REMISSION AFTER INTENSIFIED INDUCTION THERAPY - A JOINT EORTC EBMT STUDY/, Blood, 86(10), 1995, pp. 392-392
CLONALITY STUDY OF HEMATOPOIETIC MARROW PROGENITORS AND MATURE BLOOD-CELLS IN FEMALE-PATIENTS WITH MYELODYSPLASTIC SYNDROMES
Authors: DELFORGE M VANDUPPEN V DEMUYNCK H VERHOEF GEG VANDENBERGHE P ZACHEE P BOOGAERTS MA
Citation: M. Delforge et al., CLONALITY STUDY OF HEMATOPOIETIC MARROW PROGENITORS AND MATURE BLOOD-CELLS IN FEMALE-PATIENTS WITH MYELODYSPLASTIC SYNDROMES, Blood, 86(10), 1995, pp. 1328-1328
GM-CSF DURING AS WELL AS AFTER INDUCTION CHEMOTHERAPY (CT) IN ELDERLYPATIENTS WITH ACUTE MYELOID-LEUKEMIA (AML) - THE EORTC-HOVON PHASE-III TRIAL (AML-11)
Authors: LOWENBERG B SUCIU S ZITTOUN R OSSENKOPPELE G BOOGAERTS MA WIJERMANS P VELLENGA E BERNEMAN Z DEFFER AW SONNEVELD P STRYCKMANS P SOLBU G DARDENNE M DEWITTE T ARCHIMBAUD E
Citation: B. Lowenberg et al., GM-CSF DURING AS WELL AS AFTER INDUCTION CHEMOTHERAPY (CT) IN ELDERLYPATIENTS WITH ACUTE MYELOID-LEUKEMIA (AML) - THE EORTC-HOVON PHASE-III TRIAL (AML-11), Blood, 86(10), 1995, pp. 1719-1719
VARIOUS MODALITIES OF USE OF GM-CSF IN THE TREATMENT OF ACUTE MYELOGENOUS LEUKEMIA (AML) - A HOVON-SAKK RANDOMIZED STUDY (HOVON-4A)
Authors: LOWENBERG B BOOGAERTS MA VELLENGA E OSSENKOPPELE G DEKKER AW VANDERLELIE J SCHOUTEN HC FOPP M GRATWOHL A FEY M GMUR J VANPUTTEN W
Citation: B. Lowenberg et al., VARIOUS MODALITIES OF USE OF GM-CSF IN THE TREATMENT OF ACUTE MYELOGENOUS LEUKEMIA (AML) - A HOVON-SAKK RANDOMIZED STUDY (HOVON-4A), Blood, 86(10), 1995, pp. 2035-2035
CML TREATED BY LOW-DOSE INTERFERON ALFA-2B VS HYDROXYUREA ALONE - INTERIM-REPORT OF A MULTICENTER RANDOMIZED TRIAL
Authors: LOUWAGIE AC KLUINNELEMANS JC DELANNOY A VANDERBURGH JF BOOGAERTS MA BOSLY A MICHAUX JL ZACHEE P HAGEMEIJER A VANDENBERGHE H
Citation: Ac. Louwagie et al., CML TREATED BY LOW-DOSE INTERFERON ALFA-2B VS HYDROXYUREA ALONE - INTERIM-REPORT OF A MULTICENTER RANDOMIZED TRIAL, Blood, 86(10), 1995, pp. 2103-2103
PREVENTION OF VENOOCCLUSIVE DISEASE (VOD) OF THE LIVER AFTER MARROW AND BLOOD PROGENITOR-CELL TRANSPLANTATION - A PROSPECTIVE, RANDOMIZED STUDY OF DIFFERENT PROPHYLACTIC REGIMENS
Authors: DEMUYNCK H VANDENBERGHE P VERHOEF GEG ZACHEE P BOOGAERTS MA
Citation: H. Demuynck et al., PREVENTION OF VENOOCCLUSIVE DISEASE (VOD) OF THE LIVER AFTER MARROW AND BLOOD PROGENITOR-CELL TRANSPLANTATION - A PROSPECTIVE, RANDOMIZED STUDY OF DIFFERENT PROPHYLACTIC REGIMENS, Blood, 86(10), 1995, pp. 2466-2466
Risultati: 1-25 | 26-50 | 51-68